Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy ; volume:22 ; number:1 ; day:30 ; month:10 ; year:2023 ; pages:1-2 ; date:12.2023
Molecular cancer ; 22, Heft 1 (30.10.2023), 1-2, 12.2023
- Creator
-
McDermott, Martina S. J.
Browne, Brigid C.
Conlon, Neil T.
O’Brien, Neil A.
Slamon, Dennis J.
Henry, Michael
Meleady, Paula
Clynes, Martin
Dowling, Paul
Crown, John
O’Donovan, Norma
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-023-01890-z
- URN
-
urn:nbn:de:101:1-2024012409145121989033
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- McDermott, Martina S. J.
- Browne, Brigid C.
- Conlon, Neil T.
- O’Brien, Neil A.
- Slamon, Dennis J.
- Henry, Michael
- Meleady, Paula
- Clynes, Martin
- Dowling, Paul
- Crown, John
- O’Donovan, Norma
- SpringerLink (Online service)
Other Objects (12)
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
PP2A and tumor radiotherapy
Targeted therapy for HER2 positive breast cancer
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
PP2A and tumor radiotherapy
Targeted therapy for HER2 positive breast cancer
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
PP2A and tumor radiotherapy
Targeted therapy for HER2 positive breast cancer
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Novel HER2-targeted therapy to overcome trastuzumab resistance in HER2-amplified gastric cancer